Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 130, Issue 2, 2005, Pages 166-173

  Nachman, James ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acute lymphoblastic leukaemia; Avascular necrosis; Young adults

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; TIOGUANINE; VINCRISTINE; VINDESINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CYTOGENETICS; DIPLOIDY; DRUG MEGADOSE; HUMAN; IMMUNOPHENOTYPING; INCIDENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; T LYMPHOCYTE; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; CHROMOSOME ABERRATION; GENETICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOME ABERRATIONS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; PROGNOSIS; TREATMENT OUTCOME;

EID: 24944506539     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05544.x     Document Type: Review

References (29)

1. Benjamin, S., Kroll, M.E., Cartwright, R.A., Clough, J.V., Gorst, D.W., Proctor, S.J., Ross, J.R.Y., Taylor, P.R.A., Wheatley, K., Wittaker, J.A. & Stiller, C.A. (2000) Haematologists' approaches to the management of adolescents and young adults with acute leukaemia. British Journal of Haematology, 111, 1045-1050.
2. Boissel, N., Auclerc, M.F., Lheritier, V., Perel, Y., Thomas, X., Leblanc, T., Rousselot, P., Cayuela, J.M., Gabert, J., Fegueux, N., Piguet, C., Huguet-Rigal, F., Berthou, C., Boiron, J.M., Fiere, D., Leverger, G., Dombret, H. & Baruchel, A. (2003) Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. Journal of Clinical Oncology, 21, 774-780.
3. Chessells, J.M., Swansbury, G.J., Reeves, B., Bailey, C.C. & Richards, S.M. (1997) Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. British Journal of Haematology, 99, 93-100.
4. Chessells, J.M., Hall, E., Prentice, H.G., Durrant, J., Bailey, C.C. & Richards, S.M. (1998) The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia, 12, 463-473.
5. De Bont, J.M., Van Der Holt, B., Dekker, A.W., Does-van den Berg, D., Sonneveld, P. & Pieters, R., (2003) Significant difference in outcome for adolescents with lymphoblastic leukemia (ALL) treated on pediatric verses ALL protocols. Blood, 102, 222a.
6. Eden, O.B., Harrison, G., Richards, S., Lilleyman, J.S., Bailey, C.C., Chessells, J.M., Hann, I.M., Hill, F.G.H. & Gibson, B.E.S. on behalf of the Medical Research Council Childhood Leukaemia Working Party (2000) Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia. Leukemia, 14, 1980-1997.
7. Gaynon, P.S., Trigg, M.E., Heerema, N.A., Sensel, M.G., Sather, H.N., Hammond, G.D. & Bleyer, W.A. (2000) Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia, 14, 2223-2233.
8. Harms, D.O. & Janka-Schaub, G.E. on behalf of the COALL Study Group (2000) Co operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia, 14, 2234-2239.
9. Jeha, S. (2003) Who should be treating adolescents and young adults with acute lymphoblastic leukaemia? European Journal of Cancer, 21, 2579-2583.
10. Kamps, W.A., Veerman, A.J.P., Van Wering, E.R., Van Weerden, J.F., Slater, R. & Van der Does-van den Berg, A. (2000) Long-term follow-up of Dutch childhood leukemia study group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991. Leukemia, 14, 2240-2246.
11. Kantarjian, H., Thomas, D., O'Brien, S., Cortes, J., Giles, F., Jeha, S., Bueso-Ramos, C.E., Pierce, S., Shan, J., Koller, C., Beran, M., Keating, M. & Freireich, E.J. (2004) Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer, 101, 2788-2801.
12. Linker, C., Damon, L., Ries, C. & Navarro, W. (2002) Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of Clinical Oncology, 20, 2464-2471.
13. Maloney, K.W., Shuster, J.J., Murphy, S., Pullen, J. & Camitta, B.A. (2000) Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia, 12, 2276-2285.
14. Mattano, L.A., Sather, H.N., Trigg, M.E. & Nachman, J.B. (2000) Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the children's cancer group. Journal of Clinical Oncology, 18, 3262-3272.
15. Mattano, L.A., Sather, H.N., La, M.K., Nachman, J.B. & Seibel, N.L. (2003) Modified dexamethasone (DXM) reduces the incidence of treatment-related osteonecrosis (ON) in children and adolescents with higher risk acute lymphoblastic leukemia (HR ALL): a report of CCG-1961. Blood, 102, 221a.
16. Nachman, J.B., Sather, H.N., Buckley, J.D., Gaynon, P.S., Steinherz, P.G., Tubergen, D.G., Lampkin, B.C. & Hammond, G.D. (1993) Young adults 16-21 years of age at diagnosis entered on childrens cancer group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Cancer, 71, 3377-3385.
17. Nachman, J.B., Siebel, N., Sather, H.N., Steinherz, P., DeLaat, C., Fryer, D., Mattano, L.A., Hastings, C., Rubin, C., Bertolone, K., Franklin, J., Mitchell, T., Ettinger, L., Pyesmany, A. & Gaynon, P.S. (2004) Outcome for adolescent and young adults 16-21 years of age (AYA) with acute lymphoblastic leukemia (ALL) treated on the Children's Cancer Group (CCG) 1961 study. Blood, 104, 196a.
18. Pieters, R., DenBoer, M.L., Durian, M., Janka, G., Schmiegelow, K., Kaspers, G.J.L., Van Wering, E.R. & Veerman, A.J.P. (1998) Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia - implications for treatment of infants. Leukemia, 12, 1344-1348.
19. Plasschaert, S.L.A., Kamps, W.A., Vellenga, E., De Vries, E.G.E. & De Bont, E.S.J.M., (2004) Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation. Cancer Treatment Reviews, 30, 3-51.
20. Pui, C.H., Boyett, J.M., Rivera, G.K., Hancock, M.L., Sandlund, J.T., Ribeiro, R.C., Rubnitz, J.E., Behm, F.G., Raimondi, S.C., Gajjar, A., Razzouk, B., Campana, D., Kun, L.E., Relling, M.V. & Evans, W.E. (2000) Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic at St. Jude Children's Research Hospital. Leukemia, 14, 2286-2294.
21. Roman-Gomez, J., Jimenez-Velasco, A., Castillejo, J.A., Agirre, X., Barrios, M., Navarro, G., Molina, F.J., Calasanz, M.J., Prosper, F., Heiniger, A. & Torres, A. (2004) Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood, 104, 2492-2498.
22. Rubnitz, J.E., Lensing, S., Zhou, Y., Sandlund, J.T., Razzouk, B.I., Ribeiro, R.C. & Pui, C. (2004) Death during induction therapy and first remission of acute leukemia in childhood. Cancer, 101, 1677-1684.
23. Schiffer, C.A., (2003) Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both? Journal of Clinical Oncology, 21, 760-761.
24. Schrappe, M., Reiter, A., Zimmermann, M., Harbott, J., Ludwig, W.D., Henze, G., Gadner, H., Odenwald, E. & Riehm, H. (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia, 14, 2205-2222.
25. Seibel, N.L., Steinherz, P., Sather, H., Nachman, J.B., DeLaat, C., Freyer, D.R., Mattano, L.A., Hastings, C., Rubin, C., Bertolone, K., Franklin, J., Mitchell, T.L., Ettinger, L., Pyesmany, A.F. & Gaynon, P.S. (2003) Early treatment intensification improves outcome in children and adolescents with acute lymphoblastic leukemia presenting with unfavorable features who show a rapid early response to induction therapy: a report of CCG. Blood, 102, 224a.
26. Silverman, L.B., Declerck, L.Gelber, R.D., Dalton, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Lipton, J.M., Cohen, H.J. & Sallan, S.E. (2000) Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia, 14, 2247-2256.
27. Stiller, C.A., Benjamin, S., Cartwright, R.A., Clough, J.V., Gorst, D.W., Kroll, M.E., Ross, J.R.Y., Wheatley, K., Wittaker, J.A., Taylor, P.R.A. & Proctor, S.J. (1999) Patterns of care and survival for adolescents and young adults with acute leukaemia - a population-based study. British Journal of Cancer, 79, 658-665.
28. Stock, W., Sather, H., Dodge, R.K., Bloomfield, C.D., Larson, R.A. & Nachman, J. (2000) Outcome of adolescents and young adults with ALL: a comparison of children's cancer group (CCG) and cancer and leukemia group B (CALGB) regimens. Blood, 96, 476a.
29. Testi, A.M., Valsecchi, M.G., Conter, V., Vignetti, M., Nigro, L.L., Locatelli F., La Dogana, S., Specchia, G., Fabiano, F., Recchia, A., Mandelli, F., Foa, R. (2004), Difference in outcome of adolescents with acute lymphoblastic leukemia (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols. Blood, 104, 539a.